Lung Ultrasound Score in Covid 19 Infectious Disease in Critical Care (LUS-COVID19)

Last updated: April 9, 2025
Sponsor: Centre Hospitalier Universitaire de Nice
Overall Status: Completed

Phase

N/A

Condition

Covid-19

Coronavirus

Corona Virus

Treatment

lung ultrasound (LUS)

Clinical Study ID

NCT04393402
20reamedcovid03
  • Ages 18-95
  • All Genders

Study Summary

It might be necessary with Sars-Cov2 pneumopathy patient to repeat thoracic images, the tomodensitometry ones in particular. This task is difficult and nearly impossible for several reasons: respiratory and hemodynamic unstable patient, prone position and due to the high contagious nature of the disease.

The lung ultrasound is an easy tool, fast (between 5 and 10 minutes) and as a limited training.

In the context of the Sars-Cov2 epidemic, Buonsenso and al case report depict the first lung ultrasound for a Covid 19 patient.

Peng and al in Intensive Care Medicine accentuate the usefulness of this particular technic.

In the American Journal of Respiratory and Critical Care Medicine, a study has been published as a point-of-care, in which the doctors reported using the lung ultrasound with intensive and critical care patient.

In Critical Care 2016, it has been showed that ultrasound allowed with neat precisions, to predict severe ARDS patient response to the prone position, all-cause.

Another researchers team found a good correlation between lung ultrasound, the SOFA, APACHE II, CPIS score, and patient mortality.

And a new applicability in the pulmonary recruitment by PEEP titration has been presented.

The aim of this study is to evaluate the lung ultrasound in Covid19 ARDS.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Diagnosed Sars-Cov2 patient, with PCR method qualitative or quantitative as usual.

  • Intensive or critical care admission

  • ARDS with PaO2/FiO2 <300 at the admission

  • Ventilatory support or oxygen-therapy

Exclusion

Exclusion Criteria:

  • Age < 18 years-old

  • Pregnancy

  • Patient with tutor- or curatorship or in prison

Study Design

Total Participants: 14
Treatment Group(s): 1
Primary Treatment: lung ultrasound (LUS)
Phase:
Study Start date:
March 20, 2020
Estimated Completion Date:
December 31, 2022

Connect with a study center

  • CHU de Nice

    Nice, 06202
    France

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.